Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedservRegisMAL:MDS 42 Buyback Yield % is 0.00 as of Jul. 24, 2026. GuruFocus rates MAL:MDS with a GF Score™ of 42/100 and a GF Value™ of €0.92 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 419 Oil & Gas companies, MedservRegis ranks worse than 238663.25% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for MedservRegis's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MAL:MDS vs SLB, BKR, HAL: Buyback Yield % Comparison
For the Oil & Gas Equipment & Services subindustry, MedservRegis's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedservRegis Buyback Yield % vs Oil & Gas Industry
For the Oil & Gas industry and Energy sector, MedservRegis's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where MedservRegis's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedservRegis (MAL:MDS) has a Buyback Yield % of 0.00 as of Jul. 24, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on MedservRegis and its competitors. According to the industry distribution chart, MedservRegis ranks #999999 out of 419 companies in the Oil & Gas industry.
Is MedservRegis' Buyback Yield % too high?
MedservRegis' current Buyback Yield % is 0.00. Based on the distribution chart, MedservRegis ranks #999999 out of 419 companies in the Oil & Gas industry, which is in the bottom quartile relative to peers. Overall, MedservRegis has a GF Score™ of 42/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MedservRegis' Buyback Yield % compare to SLB and BKR?
According to the Oil & Gas industry distribution chart, MedservRegis ranks #999999 out of 419 companies for Buyback Yield %. This places MedservRegis in the lower half of its industry. The industry median Buyback Yield % is 0.01. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for an Oil & Gas company?
The median Buyback Yield % among Oil & Gas companies is 0.01, based on 419 companies in the industry. Companies in the top quartile (top 25%) have a Buyback Yield % significantly above this median, while those in the bottom quartile fall well below. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on MedservRegis and its competitors. For the Oil & Gas industry, the median Buyback Yield % is 0.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedservRegis's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedservRegis stock overvalued right now?
Based on GuruFocus' analysis, MedservRegis (MAL:MDS) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.92, compared to a current price of €0.69 — trading 25% below its estimated fair value. The current Buyback Yield % is 0.00. MedservRegis' overall GF Score™ is 42/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For MedservRegis (MAL:MDS), the current Buyback Yield % is 0.00 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MedservRegis (MAL:MDS) Overvalued in 2026?
Based on GuruFocus' analysis, MedservRegis stock appears to be undervalued.
The current stock price of €0.69 is trading 25% below its estimated GF Value™ of €0.92.
GuruFocus considers MedservRegis to be Modestly Undervalued.
Key valuation signals for MAL:MDS:
Buyback Yield %: 0.00
GF Value™: €0.92 vs. price of €0.69 (25% below fair value)
No single metric tells the full story. See the MAL:MDS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MedservRegis PLC is engaged in providing shore-based logistics to the offshore oil and gas industry and engineering and supply chain management for oil country tubular goods (OCTG) to support the onshore oil and gas industry. Its segment includes Integrated logistics support services; Oil country tubular goods; Trading activity and Photovoltaic farms. The company generates maximum revenue from the Integrated logistics support services segment, that Includes the provision of comprehensive logistical support services to the offshore oil and gas industry from the group's bases in Malta, Cyprus, Egypt, South America, and Africa.
42GF Score
Get the complete analysis for MAL:MDS
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MAL:MDS has been successfully added to your 
